MIRA INFORM REPORT

 

 

Report Date :

05.08.2014

 

IDENTIFICATION DETAILS

 

Name :

MUSCAT PHARMACEUTICAL TRADING LLC

 

 

Registered Office :

Mazaya Centre, Block C, Office No. 2006, Sheikh Zayed Road, P O Box 75753, Dubai

 

 

Country :

United Arab Emirates

 

 

Date of Incorporation :

26.07.2000

 

 

Com. Reg. No.:

54987

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Subject is engaged in the import and distribution of pharmaceuticals, medical devices, surgical disposables, and FMCG goods.

 

 

No. of Employees :

50

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

United Arab Emirates

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

UNITED ARAB EMIRATES - ECONOMIC OVERVIEW

 

The UAE has an open economy with a high per capita income and a sizable annual trade surplus. Successful efforts at economic diversification have reduced the portion of GDP based on oil and gas output to 25%. Since the discovery of oil in the UAE more than 30 years ago, the country has undergone a profound transformation from an impoverished region of small desert principalities to a modern state with a high standard of living. The government has increased spending on job creation and infrastructure expansion and is opening up utilities to greater private sector involvement. In April 2004, the UAE signed a Trade and Investment Framework Agreement with Washington and in November 2004 agreed to undertake negotiations toward a Free Trade Agreement with the US; however, those talks have not moved forward. The country's Free Trade Zones - offering 100% foreign ownership and zero taxes - are helping to attract foreign investors. The global financial crisis, tight international credit, and deflated asset prices constricted the economy in 2009. UAE authorities tried to blunt the crisis by increasing spending and boosting liquidity in the banking sector. The crisis hit Dubai hardest, as it was heavily exposed to depressed real estate prices. Dubai lacked sufficient cash to meet its debt obligations, prompting global concern about its solvency. The UAE Central Bank and Abu Dhabi-based banks bought the largest shares. In December 2009 Dubai received an additional $10 billion loan from the emirate of Abu Dhabi. Dependence on oil, a large expatriate workforce, and growing inflation pressures are significant long-term challenges. The UAE's strategic plan for the next few years focuses on diversification and creating more opportunities for nationals through improved education and increased private sector employment.

 

Source : CIA

 

 

 

SUMMARY

 

Company Name                                     :MUSCAT PHARMACEUTICAL TRADING LLC

Country of Origin                                    : Dubai, United Arab Emirates

Legal Form                                            : Limited Liability Company - LLC

Registration Date                                   : 26th July 2000

Commercial Registration Number            : 54987, Dubai

Trade Licence Number                            : 519815

Chamber Membership Number                : 59689

Issued Capital                                        : UAE Dh 1,500,000

Paid up Capital                                      : UAE Dh 1,500,000

Total Workforce                                     : 50

Activities                                               : Import and distribution of pharmaceuticals, medical devices, surgical

                                                              disposables, and FMCG

Financial Condition                                 : Undetermined

Payments                                             : Nothing detrimental uncovered

 

 

 

COMPANY NAME

 

MUSCAT PHARMACEUTICAL TRADING LLC

 

 

ADDRESS

 

Registered & Physical Address

 

Building             : Mazaya Centre, Block C, Office No. 2006

Street               : Sheikh Zayed Road

PO Box             : 75753

Town                 : Dubai

Country             : United Arab Emirates

Telephone         : (971-4) 3437070

Facsimile          : (971-4) 3438778

Mobile               : (971-50) 6256515

Email                : mpdxb@emirates.net.ae

 

Premises

 

Subject operates from a medium sized suite of offices that are rented and located in the Central Business Area of Dubai.

 

 

KEY PRINCIPALS

 

Name                                                   Nationality                   Position

 

Mohamed Mir Hashem Khoory                  Emirati                        Managing Director

 

 

LEGAL FORM & OWNERS

 

Date of Establishment              : 26th July 2000

 

Legal Form                              : Limited Liability Company - LLC

 

Commercial Reg. No.              : 54987, Dubai

 

Trade Licence No.                   : 519815 (Expires 25/07/2015)

 

Chamber Member No.             : 59689

 

Issued Capital                          : UAE Dh 1,500,000

 

Paid up Capital                        : UAE Dh 1,500,000

 

 

Name of Shareholder (s)                                              Percentage

 

Muscat Pharmacy LLC                                                   49%

            Oman

 

Mohamed Mir Hashem Khoory                                          51%

 

 

OPERATIONS

 

Activities: Engaged in the import and distribution of pharmaceuticals, medical devices, surgical disposables, and FMCG goods.

 

 Distribution coverage in 2012 was over 800 retail outlets.

 

Import Countries: India, Oman, Australia and Poland

 

International Suppliers:

 

Ranbaxy Laboratories Limited                                                     India

National Pharmaceutical Industries Co. (SAOG) (NPI)                   Oman

Oman Pharmaceutical Products Co. L.L.C. (OPP)                        Oman

Valeant International Pharmaceuticals                                         Australia

Biogend                                                                                    Poland

 

Brand Names: REVITAL, RUB A535, DERMA VEEN, & MANUKA

 

Subject has a workforce of 50 employees.

 

 

FINANCIAL DATA

 

Companies registered in Dubai, United Arab Emirates are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

Commercial Bank of Dubai

Baniyas Street

Deira

PO Box: 1709

Dubai

Tel: (971-4) 2227121 / 2253222

Fax: (971-4) 2220943 / 2254565

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.61.02

UK Pound

1

Rs.102.69

Euro

1

Rs.81.91

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

TPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.